Loading company…
Seventh Sense Biosystems develops minimally invasive blood collection devices.
Its TAP devices use bladeless microneedles to collect blood at home or in decentralized clinical settings. They are intended for patients, healthcare providers and research institutions. Founded in 2008 in Medford, US, the company raised USD 21.000 mn in Series B funding led by Flagship Pioneering.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in